En español
NIDA

NIDA Notes Advanced Search

Specific Drugs

Drug Topics

Related Topics

Do you like these search results?

Your search for Treatment Research returned 40 results. Search again.

Treatment

Prescription Opioid Misuse Treatment Leverages Mindfulness To Amplify Natural Rewards

Mindfulness-Oriented Recovery Enhancement (MORE) reduces opioid misuse among chronic pain patients. MORE shifts patients' attention away from drug cues and toward cues for natural rewards.

Treatment

Switching to Reduced-Nicotine Cigarettes May Aid in Quitting Smoking

Smokers who switch to cigarettes with very low nicotine content may experience mild and transient increases in some withdrawal symptoms. Cigarettes with reduced nicotine will be easier to quit than the cigarettes marketed at present.

Treatment

Outcomes of Computerized CBT Rival Those of Clinician-Delivered CBT

A clinical trial found that patients who self-administered cognitive behavioral therapy (CBT) using computerized training modules reduced their drug use as much as patients who received clinician-delivered CBT, and they maintained this advantage through a 6-month follow-up.

Treatment

In Animals, Opioid Combination Shows Promise for Safer Pain Relief

In rats, the combination treatment of oxycodone/nalfurafine had lower levels of abuse liability and produced less respiratory depression than oxycodone alone.

Treatment

Novel Compound Alleviates Hard-to-Treat Pain in Mice

A novel compound called GAT211 alleviates inflammatory and neuropathic pain in mice without producing tolerance or signs of abuse liability.

Treatment

Cigarette Smoking Increases the Likelihood of Drug Use Relapse

Research suggests that helping patients quit and remain abstinent from smoking may improve their chances for sustained recovery from use of other drugs.

Narrative of Discovery

Narrative of Discovery: The Quest for a Medication To Treat Methamphetamine Addiction, Part 3

Dr. Linda Dwoskin feels just one small step away from success in her effort to develop the first ever medication to treat methamphetamine addiction.

Treatment

Fear of Distress Signals Risk for Opioid Misuse in Chronic Pain Patients

Among patients with chronic pain, those who reported less ability to tolerate physical or emotional distress were more likely to misuse opioid analgesics.

Narrative of Discovery

Narrative of Discovery: Can Magnets Treat Cocaine Addiction? Part 3

In the final installment of this series, Dr. Diana Martinez navigates the process for receiving NIH funding to test the efficacy of using transcranial magnetic stimulation as treatment for cocaine addiction.

Treatment

Buprenorphine Benefits Waitlisted Seekers of Opioid Treatment

In two pilot clinical trials, buprenorphine helped participants reduce their illicit opioid use and injection drug use while awaiting admission to a methadone or buprenorphine treatment program. Researchers minimized the risks for improper use or diversion of the study medication by giving it to trial participants in a computerized, tamper-proof device that dispenses one dose each day.

Treatment

Nonmedical Treatment for Cocaine Addiction Shows Promise in Pilot Trial

Patients who received transcranial magnetic stimulation (TMS) were more likely to abstain from cocaine than patients who received medications for symptoms associated with abstinence. Researchers concluded that TMS appears to be safe and its efficacy as a treatment for cocaine addiction deserves to be evaluated in a larger clinical trial.

Treatment

Messages Shore Up Support for Making Life-Saving Anti-Overdose Medication Widely Available

Public health messages can increase public approval for making naloxone legally available to friends and relatives of opioid users to administer if an overdose occurs.

Treatment

Quinine as a Tracer for Medication Adherence

Patients who don’t take their medications as prescribed often put themselves at risk for problems including misdiagnoses, complications, and death. A study suggests that adding low doses of quinine to patients’ medications could provide an inexpensive, reliable, and safe method of monitoring whether patients are taking their medications as directed.

Treatment

Slow-Release Amphetamine Medication Benefits Patients With Comorbid Cocaine Addiction and ADHD

Treatment with an extended-release stimulant medication plus cognitive behavioral therapy was associated with reductions in cocaine use and in attention-deficit/hyperactivity disorder symptoms in patients with both disorders.

Narrative of Discovery

Narrative of Discovery: Can Magnets Treat Cocaine Addiction? Part 2

During investigations into using transcranial brain stimulation (TMS) to treat cocaine abuse, two projects take diverging paths. One researcher moves to the next stage, while another is forced to cut his trial short. 

Treatment

Dual Regimen Aims To Shorten Medication-Assisted Therapy

Treatment that combines use of Bp/Nx and memantine may enable young adults addicted to opioids establish lasting abstinence after a relatively brief course of medication-assisted therapy, a pilot trial suggests.

Narrative of Discovery

Narrative of Discovery: In Search of a Medication To Treat Methamphetamine Addiction, Part 2

When lobeline turned out not to be the answer, it became a starting point. Dr. Linda Dwoskin and her team set out to transform the molecule into something more effective and with fewer side effects.

Treatment

Testing a Prospective Medication To Help People Avoid Relapse

This NIDA Notes animation depicts a basic experiment that researchers use to test whether a prospective new medication can prevent relapse to drug addiction.

Treatment

ED-Initiated Buprenorphine Outperforms Referral or SBIRT for ED Patients With Opioid Addiction

Emergency department visits present prime opportunities to identify people with opioid addiction and provide them with onsite initiation of treatment with buprenorphine/naloxone.

Treatment

Long-Term Follow-Up of Medication-Assisted Treatment for Addiction to Pain Relievers Yields “Cause for Optimism”

In the first long-term follow-up of patients treated with buprenorphine/naloxone for addiction to opioid pain relievers, half reported that they were abstinent from the drugs 18 months after starting the therapy.

Treatment

Digital Addiction Therapies Affirm Promise in Replication and Large Trial

Two computerized programs improved outcomes when they were used to supplement or partially replace in-person behavioral therapy for drug addiction in recent NIDA-sponsored trials.

Narrative of Discovery

Narrative of Discovery: Can Magnets Treat Cocaine Addiction?

Two researchers share their reasons for researching transcranial magnetic stimulation (TMS) for treating cocaine addiction, and describe challenges to moving forward this potentially promising therapy.

Treatment

A Rapid Teen Substance Use Screening Tool for Clinicians

Answers to three simple questions can help a busy health care provider flag a teen’s problematic use of alcohol, tobacco, or marijuana.

Treatment

Electronic Questionnaire Quickly Rates Teens’ Substance Use

With a few simple questions, a new screening tool detects whether a teen is likely to have a mild-to-moderate or a severe substance use disorder.

Treatment

Study Ranks Recovery Assets in Cocaine Addiction

A can-do attitude, ability to cope with potential triggers for drug use, readiness to change, and participation in self-help programs are major assets for people trying to recover from cocaine addiction.

Treatment

Text Messaging Aftercare Intervention Cuts Youths’ Risk for Relapse

An interactive mobile texting aftercare program has shown promise as a means to help teens and young adults engage with post-treatment recovery activities and avoid relapse. The program reduced young people’s odds of relapsing by half compared with standard aftercare.

Treatment

Dr. Thomas Kosten Q & A: Vaccines To Treat Addiction

In this article and accompanying podcast, Dr. Thomas Kosten discusses the idea and current status of antidrug vaccines to treat substance use and addiction.

Treatment

Study Points to Individualized Therapy for Opioid Addiction

Trial participants who were addicted to opioid painkillers and did not inject drugs stayed in treatment longer and achieved better outcomes than those who were addicted to heroin or injected drugs.

Treatment

Patients Addicted to Opioid Painkillers Achieve Good Results With Outpatient Detoxification

A significant portion of individuals who are addicted to opioid painkillers may initiate and maintain abstinence with a brief but intensive outpatient detoxification treatment followed by opioid antagonist therapy using naltrexone.

Narrative of Discovery

Narrative of Discovery: In Search of a Medication To Treat Methamphetamine Addiction

This is the first in a series of NIDA Notes articles that will follow a team of researchers seeking a medication for methamphetamine addiction. This installment describes the early promise of the compound lobeline and the new directions the team discovered in studying it.

Treatment

Dr. Kevin M. Gray Q & A: A Potential Medication for Marijuana Dependence

Dr. Kevin M. Gray discusses why it’s the perfect time for discovering new evidence-based treatments for marijuana dependence. In an accompanying podcast, he discusses a clinical trial that examines NAC’s potential as a treatment for marijuana dependence among adults.

Treatment

New Approach Uses Immune Cells To Deliver Anti-HIV Medications

Nano-antiretroviral therapy (nano-ART) turns macrophages—one of the very cell types that HIV uses to replicate and spread through the body—into carriers for anti-HIV medications. The approach has the potential to make treatment for HIV easier and more effective.

Treatment

Training Workshops Boost Approval of Contingency Management

Clinicians associated with the Veterans Administration looked more favorably upon contingency management after attending training workshops on the use of the intervention. Despite being highly effective at decreasing drug use, contingency management is one of the least used among proven substance abuse treatments.

Basic Science

Gene Variants Reduce Opioid Risks

Two recent studies suggest that genotyping may enable clinicians to base therapies on individual patients’ potential responsiveness to opioid drugs’ therapeutic effects and vulnerability to their harmful effects.

NIDA @ Work

Dr. Joni Rutter Q&A: How Basic Science Is Tackling Addiction

One of NIDA’s goals is to try to understand the individual differences that contribute to whether or not someone who takes a drug will become addicted to it. Dr. Rutter’s research focuses on three types of differences: Environmental, developmental, and genetic and epigenetic.

Prevention

Expanded HIV Screening Projected To Decrease Spread of the Virus

Intensified screening for HIV among injection drug users receiving opioid agonist therapy could prevent more than twice as many new infections as current screening practice. A recent study based on mathematical modeling found that screening every 6 months instead of annually, and adding viral RNA testing to the currently used HIV antibody testing, could improve both effectiveness and cost-effectiveness.

Treatment

Study: Treat Jail Detainees’ Drug Abuse To Lower HIV Transmission

Active drug use before incarceration was associated with decreased engagement in HIV treatment among HIV-infected jail detainees. The severity of drug dependence correlated with worsening measures of engagement in HIV treatment. The study concludes that evidence-based treatment for drug abuse in jails may result in improved HIV treatment outcomes, which in turn could help slow HIV-transmission rates in the United States.

Treatment

Microneedle Milestone: One Week of Transdermal Drug Delivery

Microneedles are an innovative technique for delivering medications through the skin, a route that could particularly benefit patients receiving naltrexone therapy for opioid and alcohol dependence. Researchers have found a way to use the transdermal technique to deliver a single treatment of naltrexone that lasts for 7 days.

Treatment

California Reaped Large Savings by Diverting Drug-Using Offenders Into Treatment

California’s Proposition 36, which allows qualified drug offenders to enter substance use treatment rather than go to jail or prison, saved the state close to $100 million in its first year.

Treatment

HIV Infection Accelerates Hepatitis C–Related Liver Fibrosis

Study patients with HIV­­–hepatitis C coinfection progressed to successive degrees of severity of liver fibrosis 9 years sooner than those infected with HCV alone. Further findings from the study suggest that suppressing HIV with antiretroviral medications may slow HCV-related liver fibrosis.

NIDA Notes

Tags

Drug Topics

Drugs of Abuse

Population Groups

Related Topics